Therapy of tuberculosis in mice by DNA vaccination

Douglas B. Lowrie; Ricardo E. Tascon; Vania L. D. Bonato; Valeria M. F. Lima; Lucia H. Faccioli; Evangelos Stavropoulos; M. Joseph Colston; Robert G. Hewinson; Karin Moelling; Celio L. Silva

doi:10.1038/22326

journal article Jul 01, 1999

Therapy of tuberculosis in mice by DNA vaccination

Douglas B. Lowrie Ricardo E. Tascon Vania L. D. Bonato Valeria M. F. Lima Lucia H. Faccioli

Evangelos Stavropoulos M. Joseph Colston Robert G. Hewinson Karin Moelling

Celio L. Silva

Nature Vol. 400 No. 6741 pp. 269-271 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/22326

Topics

No keywords indexed for this article. Browse by subject →

References

30

[1]

Kochi, A. Global challenge of tuberculosis. Lancet 44, 608–609 (1994).

[2]

Bloom, B. R. & Fine, P. E. M. in Tuberculosis: Pathogenesis, Protection, and Control (ed. Bloom, B. R.) 531–557 (American Society for Microbiology, Washington DC, (1994). 10.1128/9781555818357.ch31

[3]

Hong Kong Chest Service & British Medical Research Council. Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Tubercle 63, 89–98 (1982). 10.1016/s0041-3879(82)80044-5

[4]

Young, D. B. & Duncan, K. Prospects for new interventions in the treatment and prevention of mycobacterial disease. Annu. Rev. Microbiol. 49, 641–673 (1995). 10.1146/annurev.mi.49.100195.003233

[5]

Tascon, R. E. et al. Vaccination against tuberculosis by DNA injection. Nature Med. 2, 888–892 (1996). 10.1038/nm0896-888

[6]

Huygen, K. et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. 2, 893–898 (1996). 10.1038/nm0896-893

[7]

Zhu, X. J. et al. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J. Immunol. 158, 5921–5926 (1997). 10.4049/jimmunol.158.12.5921

[8]

Bonato, V. L. D., Lima, V. M. F., Tascon, R. E., Lowrie, D. B. & Silva, C. L. Identification and characterization of protective T cells in hsp65 DNA vaccinated and Mycobacterium tuberculosis infected mice. Infect. Immun. 66, 169–175 (1998). 10.1128/iai.66.1.169-175.1998

[9]

Stenger, S. et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121–125 (1998). 10.1126/science.282.5386.121

[10]

Altare, F. et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280, 1432–1435 (1998). 10.1126/science.280.5368.1432

[11]

Donnelly, J. J., Ulmer, J. B., Shiver, J. W. & Liu, M. A. DNA vaccines. Annu. Rev. Immunol. 15, 617–648 (1997). 10.1146/annurev.immunol.15.1.617

[12]

Orme, I. M., Roberts, A. D., Griffin, J. P. & Abrams, J. S. Cytokine secretion by CD4 T-lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 15, 518–525 (1993). 10.4049/jimmunol.151.1.518

[13]

Zhang, M. et al. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63, 3231–3234 (1995). 10.1128/iai.63.8.3231-3234.1995

[14]

Krieg, A. M., LoveHoman, L., Yi, A. K. & Harty, J. T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocyto genes challenge. J. Immunol. 161, 2428–2434 (1998). 10.4049/jimmunol.161.5.2428

[15]

Lai, W. C., Pakes, S. P., Ren, K., Lu, Y. S. & Bennett, M. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. J. Immunol. 158, 2513–2516 (1997). 10.4049/jimmunol.158.6.2513

[16]

Johnston, S. A. & Barry, M. A. Genetic to genomic vaccination. Vaccine 15, 808–809 (1997). 10.1016/s0264-410x(96)00276-9

[17]

Lowrie, D. B., Silva, C. L., Colston, M. J., Ragno, S. & Tascon, R. E. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 15, 834–838 (1997). 10.1016/s0264-410x(97)00073-x

[18]

Matsumoto, S. et al. Cloning and sequencing of a unique antigen MPT70 from Mycobacterium tuberculosis H37Rv and expression in BCG using E-coli Mycobacteria shuttle vector. Scand. J. Immunol. 41, 281–287 (1995). 10.1111/j.1365-3083.1995.tb03565.x

[19]

Hewinson, R. G., Michell, S. L., Russell, W. P., McAdam, R. A. & Jacobs, W. R. Molecular characterization of MPT73: a seroreactive antigen of Mycobacterium tuberculosis with homology to MPT70. Scand. J. Immunol. 43, 490–499 (1996). 10.1046/j.1365-3083.1996.d01-78.x

[20]

Trinchieri, G. Immunobiology of interleukin-12. Immunol. Res. 17, 269–278 (1998). 10.1007/bf02786451

[21]

Flynn, J. L. et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J.Immunol. 155, 2515–2524 (1995). 10.4049/jimmunol.155.5.2515

[22]

Cooper, A. M., Magram, J., Ferrante, J. & Orme, I. M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186, 39–45 (1997). 10.1084/jem.186.1.39

[23]

deJong, R. et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280, 1435–1438 (1998). 10.1126/science.280.5368.1435

[24]

Mitchison, D. A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66, 219–225 (1985). 10.1016/0041-3879(85)90040-6

[25]

McCune, R. M., Feldmann, F. M., Lambert, H. P. & McDermott, W. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med. 123, 445–468 (1966). 10.1084/jem.123.3.445

[26]

Wiegeshaus, E., Balasubramanian, V. & Smith, D. W. Immunity to tuberculosis from the perspective of pathogenesis. Infect. Immun. 57, 3671–3676 (1989). 10.1128/iai.57.12.3671-3676.1989

[27]

Smith, P. G. & Moss, A. R. in Tuberculosis: Pathogenesis, Protection, and Control (ed. Bloom, B. R.) 47–59 (American Society for Microbiology, Washington DC, (1994). 10.1128/9781555818357.ch4

[28]

Tascon, R. E. et al. in Vaccine Design: The Role of Cytokine Networks (eds Gregoriadis, G., McCormack, B. & Allison, A. C.) 181–185 (Plenum, New York, (1997). 10.1007/978-1-4899-0062-3_18

[29]

Chapman, B. S., Thayer, R. M., Vincent, K. A. & Haigwood, N. L. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19, 3979–3986 (1991). 10.1093/nar/19.14.3979

[30]

Schultz, J., Pavlovic, J., Strack, B., Nawrath, M. & Moelling, K. Long-lasting anti-metastatic efficiency of IL-12-encoding plasmid DNA. Hum. Gene Ther. (in the press).

Cited By

360

Bioinformatics analysis, immunogenicity, and therapeutic efficacy evaluation of a novel multi-stage, multi-epitope DNA vaccine for tuberculosis

Jinzhong Guo, Zaixing Jia · 2025

International Immunopharmacology

BCG-derived acellular membrane vesicles elicit antimycobacterial immunity and innate immune memory

Takehiro Yamaguchi, Noriaki Samukawa · 2025

Frontiers in Immunology

Policy-driven ecosystems for new vaccine development

Julia Fan Li, Elizabeth Garnsey · 2014

Technovation

New drug candidates and therapeutic targets for tuberculosis therapy

Ying Zhang, Katrin Post-Martens · 2006

Drug Discovery Today

Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice

C L Silva, V L D Bonato · 2004

Gene Therapy

M. tuberculosis persistence, latency, and drug tolerance

James E Gomez, John D McKinney · 2004

Tuberculosis

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis

S-J Ha, B-Y Jeon · 2003

Gene Therapy

Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis

Jennifer L. Taylor, Oliver C. Turner · 2003

Infection and Immunity

How Far Have We Reached in Tuberculosis Vaccine Development?

Himanshu Kumar, Dheeraj Malhotra · 2003

Critical Reviews in Microbiology

Tuberculosis vaccines

Douglas B Young, Graham R Stewart · 2002

British Medical Bulletin

Immunology of Tuberculosis

JoAnne L. Flynn, John Chan · 2001

Annual Review of Immunology

DNA Vaccines

Yukio Koide, Toshi Nagata · 2000

Japanese Journal of Pharmacology

Metrics

360

Citations

30

References

Details

Published: Jul 01, 1999
Vol/Issue: 400(6741)
Pages: 269-271
License: View

Authors

Evangelos Stavropoulos

Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland; Max Planck Institute for Molecular Genetics, Berlin, Germany

C

Celio L. Silva

Cite This Article

Douglas B. Lowrie, Ricardo E. Tascon, Vania L. D. Bonato, et al. (1999). Therapy of tuberculosis in mice by DNA vaccination. Nature, 400(6741), 269-271. https://doi.org/10.1038/22326

Therapy of tuberculosis in mice by DNA vaccination

You May Also Like